This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
DOM-Zopiclone (2015-09-25)
- Starting date:
- September 25, 2015
- Posting date:
- October 6, 2015
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-55152
Affected Products
DOM-Zopiclone
Reason
These lots may contain oversized tablets exceeding the maximum recommended daily dose of 7.5 mg.
Depth of distribution
Wholesalers and pharmacies in Canada
Affected products
DOM-Zopiclone
DIN, NPN, DIN-HIM
DIN 02240823
Dosage form
Tablet
Strength
7.5 mg
Lot or serial number
- 470881
- 470883
- 487797
- 487780
Companies
- Recalling Firm
-
Pharmapar Inc
5950 Cote de Liesse, Bureau 100
Ville Mont Royal
H4T 1E2
Quebec
CANADA
- Marketing Authorization Holder
-
Dominion Pharmacal
6111 Royalmount, Suite 100
Montreal
H4P 2T4
Quebec
CANADA